2015 Antineoplastics

Question 13

Identify the drug, occasionally still used in the treatment of chronic myeloid leukemia (CML), that is a direct inhibitor of ribonucleotide reductase, and which synchronizes cells in a radiation-sensitive phase of the cell cycle. Answer
            A.        Busulfan
            B.        Hydroxyurea
            C.        Imatinib
            D.        Interferon α
            E.        6-Mercaptopurine

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM